Related Experiment Videos
One year in review 2017: systemic vasculitis
Elena Elefante1, Sara Monti2, Milena Bond3
1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Insights
This review highlights recent advances in understanding systemic vasculitis, focusing on novel biomarkers for improved diagnosis and targeted therapies for large- and small-vessel conditions.
Area of Science:
- Rheumatology and Immunology
- Internal Medicine
Background:
- Systemic vasculitis encompasses diverse and debilitating conditions.
- Recent research focuses on the pathophysiology, clinical features, and treatment of large- and small-vessel vasculitis.
Purpose of the Study:
- To critically review recent literature on systemic vasculitis.
- To identify novel biomarkers for diagnosis and prognosis.
- To explore the impact of these biomarkers on current and future therapies.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of research on pathogenetic pathways.
- Focus on diagnostic and prognostic biomarkers for vasculitis.
Main Results:
- Emerging biomarkers show potential for improved disease understanding.
- New insights into pathogenetic pathways are being uncovered.
- Biomarker discovery aims to enable more targeted treatment strategies.
Conclusions:
- Continued research into biomarkers is crucial for advancing vasculitis treatment.
- Novel biomarkers may lead to personalized medicine approaches.
- Understanding pathogenetic pathways is key to developing effective therapies.
Abstract:
Systemic vasculitis is a group of heterogeneous, disabling disorders. Great interest has recently arisen in pathophysiology, clinical phenotypes and therapy of large- and small-vessel vasculitis. The general work hypothesis has been to promote research focused on disease-related pathogenetic pathways, with the ultimate goal of identifying novel diagnostic and prognostic biomarkers, thus leading towards more effective targeted treatments. Following the previous annual reviews of this series, we will hereby provide a critical digest of the recent literature on small- and large-vessel systemic vasculitis, with a specific focus on novel possible disease-related biomarkers and their impact on current and future therapies.